[1]
“AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH”, GCM, vol. 1, no. 6, pp. 709–721, Jun. 2026, Accessed: Aug. 25, 2026. [Online]. Available: https://econferencia.com/index.php/5/article/view/1216